Otsuka and Lundbeck Receive the EC’s Approval for Rxulti to Treat Schizophrenia in Adolescents
Shots: The EC has approved Rxulti (brexpiprazole) to treat schizophrenia in pts (&...
China’s NMPA Accepts BLA of Zai Lab’s Tivdak for Recurrent or Metastatic Cervical Cancer
Shots: China’s NMPA has accepted BLA of Tivdak for the treatment of recurren...
Geron Receives the EC’s Approval for Rytelo (Imetelstat) to Treat Transfusion-Dependent Anemia due to Lower-Risk MDS
Shots: The EC has approved Rytelo to treat TD anemia in adults with very low,...
China’s NMPA Approves Kelun-Biotech's Sacituzumab Tirumotecan (sac-TMT) for EGFR-mutant NSCLC
Shots: China’s NMPA has approved label expansion of sacituzumab tirumotecan...
AstraZeneca and Ionis’ Wainzua (Eplontersen) Receives the EC’s Approval to Treat Hereditary Transthyretin-Mediated Amyloidosis wit...
Shots: The EC has approved Wainzua to treat ATTRv-PN (stage 1/2 polyneuropathy) in...
The EC Approves BMS’ Opdivo + Yervoy as 1L Treatment for Hepatocellular Carcinoma
Shots: The EC has approved Opdivo + Yervoy as 1L therapy to treat inoperable or ad...
